Valproic acid - Page 1 | CARLAT PUBLISHING

Clinical Guidance

How to Treat Bipolar Depression

November 19, 2024

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Bipolar depression is the depressive phase of bipolar disorder, and it presents very similarly to regular major depression.

Clinical Guidance

How to Medicate Manic Episodes

November 19, 2024

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

This sheet guides you in how to use medications to rapidly treat patients with severe mania.

Clinical Guidance

Bipolar Disorder Treatment Algorithm

November 19, 2024

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Bipolar mania and depression treatment algorithms

Clinical Guidance

Bipolar Disorder General Prescribing Tips

November 19, 2024

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Carlat has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Here we focus on the non-antipsychotic mood stabilizers—lithium, valproic acid, lamotrigine, carbamazepine, and oxcarbazepine

Expert Q&A

Pharmacological Treatment of Bipolar Disorder in Older Adults

January 31, 2023

John Beyer, MD

John Beyer, MD. Professor of psychiatry, Duke University Medical Center. Durham, NC. Dr. Beyer has consulted for Express Scripts. Relevant financial relationships listed for the author have been mitigated.

With numerous treatment options available for bipolar depression and mania, clinicians often struggle to navigate between medication classes in balancing side effects, efficacy, and costs. Dr. Beyer shares his expertise in choosing first-, second-, third-, and fourth-line options based on their evidence in older adults.

Clinical Update

Mood Stabilizers for Bipolar Disorder in Older Adults: Special Considerations

January 30, 2023

Rehan Aziz, MD.

Rehan Aziz, MD. Associate professor of psychiaitry and neurology, Rutgers Robert Wood Johnson Medical School. New Brunswick, NJ. Dr. Aziz has no financial relationships with companies related to this material.

We evaluate the usage, risks, and dosing of mood stabilizers to help clinicians optimize their choice of treatment.